Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
BMS to pull Tequin antibiotic from the shelves
May 1, 2006
The
Washington Post
reports that Tequin is being
withdrawn from the market
, due to blood sugar complications that it can cause.
pharmamanufacturing
The
Washington Post
reports that Tequin is being
withdrawn from the market
, due to blood sugar complications that it can cause.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Notable 2024 FDA decisions
Harnessing the power of bispecific antibodies
Virginia is for pharma lovers
Michael Annino/Shutterstock AI
Mining pharma's reshoring rush
Sponsored
Content
Special report: OT cybersecurity incident response — Are you ready?
Nevertheless, they persisted
Load More Content